<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shukra Pharmaceuticals Ltd has filed a disclosure with BSE confirming that it does not qualify as a 'Large Corporate' under SEBI regulations (circular dated October 19, 2023). The company states it does not meet the criteria specified in para 3.2 of the SEBI circular regarding fund-raising through debt securities. This is a routine compliance filing where the company is confirming its non-applicability under the regulatory framework for large entities. The filing was made on April 29, 2026, to the BSE Limited (Scrip Code: 524632).
This filing has no direct impact on shareholders as it simply confirms the company is below the threshold to be classified as a Large Corporate. It indicates the company is smaller in scale and has fewer mandatory debt-related disclosure requirements compared to larger listed entities.